Speaker Profile
MSc. MBA, Global Marketing Director, Precision Medicine, Merck
Biography
Arnaud Papin has been instrumental in establishing a precision medicine strategy aimed at supporting Merck early-stage cancer launches through advancements in early cancer detection and the management of minimal residual disease (MRD).In his role, Arnaud has led strategic assessments to identify unmet medical needs in key tumor types. He has played a crucial role in fostering cross-functional collaboration and facilitating upskilling initiatives.His leadership extends to technology assessment and prioritization, focusing on innovative approaches ranging from single and multi-cancer early detection, AI in radiology, pathology and electronic medical records. Arnaud actively identifies partnership opportunities to accelerate the clinical adoption of these technologies and is engaged in several influential consortia, including the LCPN, the BloodPac, and the MCED consortium.Separately, he led the innovation and commercial strategy in the area of ctDNA dynamics and minimal residual disease through both tumor-informed and tumor-naive approaches, paving the way to clinical adoption.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Adrian Lee, UPMC
- PMWC Award Ceremony
Pioneer Honoree: Victor Velculescu, Johns Hopkins
Luminary Honoree: Nicola Aceto, ETH Zurich
- Keynote: Early Detection of Cancer using Cell-free DNA Fragmentomes
- Victor Velculescu, Johns Hopkins - Keynote: The Power of a Blood Sample: Predictive Diagnostics and Transforming Healthcare
- Matthew Rabinowitz, Natera - Improving Sensitivity of MRD and MCED - Tumor-agnostic vs. Tumor-informed ctDNA Approaches
Chair: Adrian Lee, University of Pittsburgh
- Marija Balic, UPMC
- Ola Carl Landgren, University of Miami
- Carl Barrett, Precede Biosciences
- Jonathan Beer, BMS
- Innovative Approaches in Liquid Biopsy
Chair: Victor Velculescu, Johns Hopkins
- Adam Widman, MSKCC
- Brian Hashemi, Novigenix
- Sequencing Accuracy in Early Detection and MRD (PANEL)
Chair: Alex Sockell, PacBio
- James Hadfield, AstraZeneca
- Keynote: Keynote: Circulating Tumor Cells
- Nicola Aceto, ETH Zurich - Circulating Tumor Cells: The New Frontier
Chair: Nicola Aceto, ETH Zurich
- Min Yu, University of Maryland School of Medicine
- Matteo Ligorio, UTSW - Precision Liquid Biopsies: Innovations Across the Cancer Continuum – From Early Detection to Long-Term Monitoring
Chair: Tom Beer, Exact Sciences
- Elizabeth (Betsy) O’Donnell, Dana Farber Cancer Institute
- Arnaud Papin, Merck
- PMWC Showcase
- Wendy Winckler, Droplet Biosciences - Multi-Cancer Early Detection: Innovations and Real-World Evidence (PANEL)
Chair: Peter Bach, Delfi Dx
- Joshua Cohen, Haystack
- Lauren Leiman, BLOODPAC
- Eric Klein, Grail Bio
- Tom Beer, Exact Sciences - PMWC Showcase
- Varsha Rao, Claret Bio - PMWC Award Ceremony and Keynote
Luminary Honoree: Matthew Rabinowitz, Natera
